Net income
−$2.6M
+15.1% vs same quarter last year
EPS, diluted
−$0.58
+70.4% vs same quarter last year
Operating cash flow
−$2M
+31.9% vs same quarter last year
Operating income
−$2.6M
+16.9% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | - | −$984.2M |
| FY24 | - | −$1.1B |
| FY23 | $37.7K | −$20.7M |
| FY22 | $131.5K | −$14.3M |
| FY21 | $87K | −$15.7M |
| FY20 | - | −$26.4M |
| FY19 | - | −$15.6M |
| FY18 | - | −$9.9M |
| FY17 | $0 | −$6.7M |
| FY16 | $0 | −$7M |
| FY15 | $0 | −$11.7M |
| FY14 | $939.9K | −$5.8M |
| FY13 | $1M | −$16.1M |
| FY12 | $1.3M | −$13.1M |
| FY11 | $1.4M | −$7.7M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | - | - | - |
| FY24 | - | - | - |
| FY23 | - | −55519.9% | −54858.1% |
| FY22 | - | −10964.6% | −10864% |
| FY21 | - | −18130.3% | −18062% |
| FY20 | - | - | - |
| FY19 | - | - | - |
| FY18 | - | - | - |
| FY17 | - | - | - |
| FY16 | - | - | - |
| FY15 | - | - | - |
| FY14 | 60.7% | −618.8% | −616% |
| FY13 | 66.7% | −1570.4% | −1556.7% |
| FY12 | 34% | −933.5% | −982.9% |
| FY11 | 50.6% | −508.6% | −531.6% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | - |
| FY24 | - |
| FY23 | - |
| FY22 | −$15.4M |
| FY21 | −$13.5M |
| FY20 | - |
| FY19 | −$13M |
| FY18 | −$9.2M |
| FY17 | - |
| FY16 | −$7.1M |
| FY15 | −$5.3M |
| FY14 | −$5.7M |
| FY13 | −$6.8M |
| FY12 | −$5.2M |
| FY11 | - |
- Oragenics
- Healthcare median
Show the numbers
| Year | Oragenics | Healthcare median |
|---|---|---|
| FY25 | - | −30.6% |
| FY24 | - | −47% |
| FY23 | −54858.1% | −58% |
| FY22 | −10864% | −80.4% |
| FY21 | −18062% | −71.8% |
| FY20 | - | −62.2% |
| FY19 | - | −46.2% |
| FY18 | - | −49.6% |
| FY17 | - | −45.9% |
| FY16 | - | −36% |
| FY15 | - | −37.8% |
| FY14 | −616% | −35.5% |
| FY13 | −1556.7% | −37.1% |
| FY12 | −982.9% | −29.1% |
| FY11 | −531.6% | −27.9% |